Purchases and Sales Made in Q1 2022 in Sorrento Therapeutics, Inc. (SRNE)
This table provides information about the institutional ownership of Sorrento Therapeutics, Inc. (SRNE) during Q1 2022. The information is specifically focused on institutions that hold shares of Sorrento Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2022
Q1 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-315K- 5.94% |
$630K - $1.54M
|
4.99M
$1.65M
|
|
|
May 12, 2022
Q1 2022
|
Citigroup Inc
|
SELL
|
- |
-327K- 42.68% |
$654K - $1.6M
|
439K
$145K
|
|
|
May 16, 2022
Q1 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-328K- 86.56% |
$655K - $1.61M
|
50.9K
$16.8K
|
|
|
May 16, 2022
Q1 2022
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-373KClosed |
$747K - $1.83M
|
0
$0
|
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-928KClosed |
$1.86M - $4.55M
|
0
$0
|
|
|
May 12, 2023
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-942K- 30.13% |
$1.88M - $4.61M
|
2.18M
$721K
|
|
|
May 16, 2022
Q1 2022
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-2.19MClosed |
$4.38M - $10.7M
|
0
$0
|